VISTA: Vaccinator-Initiated Screening and TAilored Counseling for Reducing Vaccine Hesitancy
NCT04421586 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2024-01-05
Summary
The purpose of this study is to understand why parents do or do not vaccinate their children and explore what information parents need to vaccinate their children. The study will test whether information about vaccinations provided during pregnancy by a health provider (VISTA intervention) may improve the possibility that a child is vaccinated on time.
Conditions
- Vaccination Uptake
Interventions
- BEHAVIORAL
-
VISTA
VISTA will be an educational intervention.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Lavanya Vasudevan, PhD · Duke University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-02
- Primary Completion
- 2021-05-24
- Completion
- 2021-05-24
Countries
- Tanzania
Study Locations
More Related Trials
-
Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?
NCT04658680 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
NCT00480454 ·Status: COMPLETED ·Phase: PHASE1
-
Pertussis Immunization Programs in Low Income Countries - Ivory Coast
NCT03388034 ·Status: COMPLETED
-
Increasing Vaccine Uptake Among Adolescents in the Rural South
NCT04999267 ·Status: COMPLETED ·Phase: NA
-
A Study of MVA85A in Healthy Children and Infants
NCT00679159 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in Infants
NCT04351685 ·Status: COMPLETED ·Phase: PHASE3
-
Measles and BCG Vaccines for Mother and Child
NCT04899765 ·Status: RECRUITING ·Phase: PHASE4
-
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
NCT00395720 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
NCT00480558 ·Status: COMPLETED ·Phase: PHASE1
-
Testing the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125 ·Status: COMPLETED ·Phase: NA
-
Non-Specific Effects of Standard Titre Measles Vaccination
NCT00168662 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa
NCT02391415 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
NCT04975178 ·Status: RECRUITING ·Phase: PHASE3
-
Trial of Additional Measles Vaccine to Reduce Child Mortality
NCT01644721 ·Status: COMPLETED ·Phase: PHASE4
-
Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial
NCT02504203 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa
NCT05539989 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
NCT05758532 ·Status: RECRUITING ·Phase: PHASE4
-
Measles Vaccination at Health System Contacts
NCT04220671 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda
NCT04177485 ·Status: COMPLETED ·Phase: NA
-
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823 ·Status: COMPLETED ·Phase: NA
-
Missed Opportunities for Vaccine Equity
NCT04834960 ·Status: COMPLETED ·Phase: NA
-
Pertussis Immunization Programs in Low Income Countries
NCT02983487 ·Status: COMPLETED
-
Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination
NCT01650389 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
NCT00460590 ·Status: COMPLETED ·Phase: PHASE1
-
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT06470919 ·Status: COMPLETED ·Phase: NA